Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $94.5900 (0.79%) ($92.8100 - $95.0100) on Mon. Jun. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.28% (three month average) | RSI | 60 | Latest Price | $94.5900(0.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.9% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(51%) SPLV(40%) VYM(37%) DIA(36%) IVE(35%) | Factors Impacting ABBV price | ABBV will decline at least -1.64% in a week (0% probabilities). VIXM(-26%) UUP(-10%) VXX(-7%) TLT(-4%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.64% (StdDev 3.28%) | Hourly BBV | 0.7 () | Intraday Trend | 1.8% | | | |
|
5 Day Moving Average | $92.68(2.06%) | 10 Day Moving Average | $91.83(3.01%) | 20 Day Moving Average | $91.29(3.61%) | To recent high | 0% | To recent low | 46.7% | Market Cap | $166.884b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |